Found: 11
Select item for more details and to access through your institution.
Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 9, p. 1839, doi. 10.1093/jac/dkq261
- By:
- Publication type:
- Article
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.
- Published in:
- Annals of Intensive Care, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13613-022-01084-8
- By:
- Publication type:
- Article
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 3, p. 352, doi. 10.1002/jcph.2165
- By:
- Publication type:
- Article
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 166, doi. 10.1002/jcph.2149
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 2, p. 254, doi. 10.1002/jcph.1733
- By:
- Publication type:
- Article
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
- Published in:
- 2022
- By:
- Publication type:
- journal article